BioAge Labs, Inc. (BIOA)

8.19 +0.10 (+1.24%) USD  |  NASDAQ  |  Sep 22, 10:46
More

BioAge Labs Total Long Term Debt (Quarterly) : 2.121M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for BIOA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 2.121M
March 31, 2026 3.388M
December 31, 2025 4.978M
September 30, 2025 6.553M
June 30, 2025 8.116M
March 31, 2025 9.612M
December 31, 2024 8.502M
Date Value
September 30, 2024 9.94M
June 30, 2024 11.41M
March 31, 2024 12.90M
December 31, 2023 14.20M
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 49.62B
Pfizer Inc. 63.10B
Oramed Pharmaceuticals, Inc. 0.484M
Liquidia Corp. 182.90M
Neumora Therapeutics, Inc. 52.95M